Sintx Technologies, Inc. (SINT) — 10-Q Filings

10-Q Filings (6)

• Sintx Revenue Plunges 69% Amid Strategic Shift, FDA Clearance Offers Hope — Nov 12, 2025 Risk: high
  Sintx Technologies, Inc. (SINT) reported a significant decline in total revenue for the nine months ended September 30, 2025, falling to $728 thousand from $2.3
• Sintx Revenue Plummets 66% Amid Widening Losses, Shifts to Biomedical Focus — Aug 14, 2025 Risk: high
  Sintx Technologies, Inc. (SINT) reported a significant decline in total revenue for the six months ended June 30, 2025, falling to $520,000 from $1,546,000 in t
• Sintx Technologies Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Sintx Technologies, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as AMEDICA Corp, is involved in surgical a
• Sintx Technologies Files Q3 2024 10-Q Report — Nov 12, 2024 Risk: medium
  Sintx Technologies, Inc. filed its Q3 10-Q report for the period ending September 30, 2024. The company, formerly known as AMEDICA Corp, is involved in the surg
• Sintx Technologies Reports Q2 2024 Results, Revenue Declines — Aug 13, 2024 Risk: medium
  Sintx Technologies, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported revenue of $1.1 million for the three months ended June 30, 20
• Sintx Technologies, Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
  Sintx Technologies, Inc. (SINT) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Sintx Technologies, Inc. filed a 10-Q for the period ending March

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX